Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2) [clinicaltrials:NCT01096693]
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2) [clinicaltrials:NCT01096693]
Bio2RDF identifier
NCT01096693
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT01096693
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Impairment of the heart ...... m in the body as a whole.

brief title [clinicaltrials_vocabulary:brief-title]
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2012-08-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2010-03-30T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Astressin 2B
Urocortin 2
Urocortin 3
forearm blood flow
heart failure
plethysmography
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-05-10T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT01096693
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers
org study id [clinicaltrials_vocabulary:org-study-id]
SV.Procotol 2
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2012-08-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2010-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-05-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Awaiting supply of peptide from a different company
identifier
clinicaltrials:NCT01096693
title
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)
@en
type
label
Effects of Urocortins on Forea ...... ) [clinicaltrials:NCT01096693]
@en